Baner

Programme


Download the programme in PDF
Thursday, 11 May 2017
09.00–10.15
Session I. Novel mechanisms and therapies

Chairpersons: Gustavs Latkovskis (Latvia), Marcin Adamczak (Katowice, Poland), Adrian Brady (United Kingdom)

  1. Clinical use of cardiometabolic biomarkers and genetic scores

    Olle Melander (Lund, Sweden)


    Olle Melander (Lund, Szwecja)
  2. Novel concepts in vascular aging

    Stephane Laurent (Paris, France)


  3. Antihypertensive drugs – is there anything new on the horizon?

    Michel Burnier (Lausanne, Switzerland)


    Michel Burnier (Lozanna, Szwajcaria)
17.00–17.15Welcome addresses and Congress opening
17.15–18.45
Opening lectures

Chairpersons: Enrico Agabiti Rosei (Italy), Marius Miglinas (Lithuania), Krzysztof Narkiewicz (Poland)

  1. Reappraisal of the European Hypertension Guidelines

    Giuseppe Mancia (Italy)


    Giuseppe Mancia (Włochy)
  2. Resistant hypertension – 2017 update

    Konstantinos Tsioufis (Greece)


    Konstantinos Tsioufis (Grecja)
  3. Stress, hypertension and cardiovascular disease

    Krzysztof Narkiewicz (Gdansk)


19.30Welcome cocktail
Friday, 12 May 2017
10.15–10.45Poster viewing and coffee break
10.45–12.45
Session II. Progress in diagnostics

Chaipersons: Jose Julian Segura (Spain), Anna Rekhviashvili (Georgia), Päivi Korhonen (Finland)

  1. Diurnal rhythm of blood pressure and prognosis

    Ludovit Gaspar, Slavomira Filipova (Bratislava, Slovakia)


  2. The heart in hypertension

    Enrico Agabiti-Rosei (Brescia, Italy)


  3. The kidney in hypertension

    Bruno Watschinger (Vienna, Austria)


    Bruno Watschinger (Wiedeń, Austria)
  4. Endocrine hypertension – what is new?

    Jiri Widimsky Jr (Prague, Czech Republic)


    Jiri Widimsky Jr (Praga, Czechy)
  5. Big data analysis and decision support systems in hypertension

    Nadezhda Zvartau (St. Petersburg, Russia)


12.45–14.00Poster viewing and lunch
14.00–15.45
Topical Workshop Joint ESH research projects - part 1

Chairpersons: Enrico Agabiti Rosei (Italy), Jana Brguljan (Slovenja), Dragan Lovic (Serbia)

ESH Atrial Fibrillation Research Project - Enrico Agabiti Rosei (Italy)

ESH-BP Control Study - Bojan Jelaković (Croatia)

ESH Hypertension APP - Gianfranco Parati (Italy)

MASTER study - Gianfranco Parati (Italy)

    15.45–16.15Coffee break
    16.15–18.00
    Topical Workshop "Joint ESH research projects" - part 2

    Chairpersons: Bojan Jelaković (Croatia), Jan Filipovsky (Czech Republic), Thomas Weber (Austria)

    ESH Stroke Survey - Renata Cifkova (Prague, Czech Republic)

    Multicentre study on the management of acute hypertensive events - Bojan Jelaković (Croatia)

    ESH Registry  on Fibromuscular Dysplasia:

    1. The European Fibromuscular Dysplasia Initiative - aims and current status

    Alexandre Persu (Belgium)

    2. The Arcadia-Pol Study – design and present status

    Aleksander Prejbisz, Andrzej Januszewicz (Poland)

    Other projects

    Discussion

      19.30Gala Dinner (participation payment – the prior payment is required, tickets are not available on the spot)
      Saturday, 13 May 2017
      09.00–10.30
      Session III. Hypertension treatment: challenges and novel options

      Chairpersons: Manuel Carvalho Rodrigues (Portugal), Yuriy Sirenko (Ukraine), Tine De Backer (Belgium)

      1. Target blood pressure – implications of recent clinical trials

        Sverre Kjeldsen (Oslo, Norway)


        Sverre Kjeldsen (Oslo, Norwegia)
      2. Cardiovascular effects of new antidiabetic drugs

        Peter Nilsson (Lund, Sweden)


        Peter Nilsson (Lund, Szwecja)
      3. How to optimize blood pressure assessment in year 2017

        Gianfranco Parati (Milan, Italy)


        Gianfranco Parati (Milan, Włochy)
      10.30–11.00Coffee break
      11.00–13.00
      Session IV. Special populations and hypertension-related comorbidities

      Chairpersons: Martin Hausberg (Germany), Margus Viigimaa (Tallinn, Estonia), Yoto Yotov (Bulgaria)

      1. Hypertension and stroke

        Renata Cifkova (Prague, Czech Republic)


        Renata Cifkova (Praga, Czechy)
      2. Hypertension vs. atrial fibrillation

        Victor Snezhitsky (Grodno, Belarus)


      3. The correlation between arterial stiffness and coronary calcification score

        Sekib Sokolovic (Bosnia and Herzegovina)


        Sekib Sokolovic (Bośnia i Hercegowina)
      4. Hypertension and erectile dysfunction

        Margus Viigimaa (Tallinn, Estonia)


        Margus Viigimaa (Tallinn, Estonia)
      5. Hypertension in chronic kidney disease patients treated with hemodialysis

        Marcin Adamczak (Katowice, Poland)


        Marcin Adamczak (Katowice, Polska)
      13.00–13.15Concluding remarks
      13.15Lunch
      Thursday, 11 May 2017
      09.00–10.15
      Session I. Novel mechanisms and therapies

      Chairpersons: Gustavs Latkovskis (Latvia), Marcin Adamczak (Katowice, Poland), Adrian Brady (United Kingdom)

      1. Clinical use of cardiometabolic biomarkers and genetic scores

        Olle Melander (Lund, Sweden)


        Olle Melander (Lund, Szwecja)
      2. Novel concepts in vascular aging

        Stephane Laurent (Paris, France)


      3. Antihypertensive drugs – is there anything new on the horizon?

        Michel Burnier (Lausanne, Switzerland)


        Michel Burnier (Lozanna, Szwajcaria)
      17.00–17.15
      Welcome addresses and Congress opening
      17.15–18.45
      Opening lectures

      Chairpersons: Enrico Agabiti Rosei (Italy), Marius Miglinas (Lithuania), Krzysztof Narkiewicz (Poland)

      1. Reappraisal of the European Hypertension Guidelines

        Giuseppe Mancia (Italy)


        Giuseppe Mancia (Włochy)
      2. Resistant hypertension – 2017 update

        Konstantinos Tsioufis (Greece)


        Konstantinos Tsioufis (Grecja)
      3. Stress, hypertension and cardiovascular disease

        Krzysztof Narkiewicz (Gdansk)


      19.30
      Welcome cocktail
      Friday, 12 May 2017
      10.15–10.45
      Poster viewing and coffee break
      10.45–12.45
      Session II. Progress in diagnostics

      Chaipersons: Jose Julian Segura (Spain), Anna Rekhviashvili (Georgia), Päivi Korhonen (Finland)

      1. Diurnal rhythm of blood pressure and prognosis

        Ludovit Gaspar, Slavomira Filipova (Bratislava, Slovakia)


      2. The heart in hypertension

        Enrico Agabiti-Rosei (Brescia, Italy)


      3. The kidney in hypertension

        Bruno Watschinger (Vienna, Austria)


        Bruno Watschinger (Wiedeń, Austria)
      4. Endocrine hypertension – what is new?

        Jiri Widimsky Jr (Prague, Czech Republic)


        Jiri Widimsky Jr (Praga, Czechy)
      5. Big data analysis and decision support systems in hypertension

        Nadezhda Zvartau (St. Petersburg, Russia)


      12.45–14.00
      Poster viewing and lunch
      14.00–15.45
      Topical Workshop Joint ESH research projects - part 1

      Chairpersons: Enrico Agabiti Rosei (Italy), Jana Brguljan (Slovenja), Dragan Lovic (Serbia)

      ESH Atrial Fibrillation Research Project - Enrico Agabiti Rosei (Italy)

      ESH-BP Control Study - Bojan Jelaković (Croatia)

      ESH Hypertension APP - Gianfranco Parati (Italy)

      MASTER study - Gianfranco Parati (Italy)

        15.45–16.15
        Coffee break
        16.15–18.00
        Topical Workshop "Joint ESH research projects" - part 2

        Chairpersons: Bojan Jelaković (Croatia), Jan Filipovsky (Czech Republic), Thomas Weber (Austria)

        ESH Stroke Survey - Renata Cifkova (Prague, Czech Republic)

        Multicentre study on the management of acute hypertensive events - Bojan Jelaković (Croatia)

        ESH Registry  on Fibromuscular Dysplasia:

        1. The European Fibromuscular Dysplasia Initiative - aims and current status

        Alexandre Persu (Belgium)

        2. The Arcadia-Pol Study – design and present status

        Aleksander Prejbisz, Andrzej Januszewicz (Poland)

        Other projects

        Discussion

          19.30
          Gala Dinner (participation payment – the prior payment is required, tickets are not available on the spot)
          Saturday, 13 May 2017
          09.00–10.30
          Session III. Hypertension treatment: challenges and novel options

          Chairpersons: Manuel Carvalho Rodrigues (Portugal), Yuriy Sirenko (Ukraine), Tine De Backer (Belgium)

          1. Target blood pressure – implications of recent clinical trials

            Sverre Kjeldsen (Oslo, Norway)


            Sverre Kjeldsen (Oslo, Norwegia)
          2. Cardiovascular effects of new antidiabetic drugs

            Peter Nilsson (Lund, Sweden)


            Peter Nilsson (Lund, Szwecja)
          3. How to optimize blood pressure assessment in year 2017

            Gianfranco Parati (Milan, Italy)


            Gianfranco Parati (Milan, Włochy)
          10.30–11.00
          Coffee break
          11.00–13.00
          Session IV. Special populations and hypertension-related comorbidities

          Chairpersons: Martin Hausberg (Germany), Margus Viigimaa (Tallinn, Estonia), Yoto Yotov (Bulgaria)

          1. Hypertension and stroke

            Renata Cifkova (Prague, Czech Republic)


            Renata Cifkova (Praga, Czechy)
          2. Hypertension vs. atrial fibrillation

            Victor Snezhitsky (Grodno, Belarus)


          3. The correlation between arterial stiffness and coronary calcification score

            Sekib Sokolovic (Bosnia and Herzegovina)


            Sekib Sokolovic (Bośnia i Hercegowina)
          4. Hypertension and erectile dysfunction

            Margus Viigimaa (Tallinn, Estonia)


            Margus Viigimaa (Tallinn, Estonia)
          5. Hypertension in chronic kidney disease patients treated with hemodialysis

            Marcin Adamczak (Katowice, Poland)


            Marcin Adamczak (Katowice, Polska)
          13.00–13.15
          Concluding remarks
          13.15
          Lunch

          ORGANIZATOR

          PATRONAT MEDIALNY

          PARTNER

          Via Medica
          Via Medica

          Strony konferencji Grupy Via Medica wykorzystują pliki cookies. Opcje dotyczące cookies można zmienić w ustawieniach przeglądarki internetowej.
          Korzystanie z niniejszej strony bez zmiany ustawień dotyczących cookies oznacza, że będą one zapisane w pamięci komputera. Czym są i do czego służą pliki cookie możesz dowiedzieć się na stronie www.wszystkoociasteczkach.pl